IP Library Granted Patent US 9,597,375
Granted Patent B2
US 9,597,375 · App. 12/582,595 · Granted Mar 21, 2017

Coagulation and fibrinolytic cascades modulator

Inventors: James H. Morrissey (Champaign, IL); Stephanie A. Smith (Champaign, IL); Roberto Docampo (Athens, GA); Nicola J. Mutch (Urbana, IL)
Assignee: The Board of Trustees of the University of Illinios
A61K38/36C12Q1/56G01N33/86
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,597,375
App. No.
12/582,595
Granted
Mar 21, 2017
Kind
B2
Abstract

Methods for stopping or slowing bleeding from a wound are provided; these methods include the step of administering a composition comprising a polyphosphate (polyP) to blood from the wound at the site of the wound. Also provided are methods for slowing fibrinolysis and for blocking the action of Tissue Factor Pathway Inhibitor (TFPI) with the use of polyP.

Claims (8)

1. A method of stopping or slowing bleeding from a wound, comprising contacting blood from the wound at the site of the wound with a composition comprising (i) polyphosphate (polyP n ), wherein n is at least 25, and (ii) a pharmaceutical carrier.

2. The method of claim 1 , wherein the composition is in unit dosage form.

3. The method of claim 1 , wherein the pharmaceutical carrier comprises a solid support.

4. A method of claim 1 , wherein the composition is sterile.

5. A method of stopping or slowing bleeding from a wound, comprising contacting blood from the wound at the site of the wound with polyphosphate (polyP n ), wherein n is at least 25.

6. A method of blocking Tissue Factor Pathway Inhibitor (TFPI) in a clotting assay, comprising administering polyphosphate (polyP n ) as an activator of clotting in an assay composition comprising TFPI, wherein n is at least 25.

7. The method of claim 6 , wherein the composition comprises a thromboplastin reagent.

8. A method of blocking Tissue Factor Pathway Inhibitor (TFPI) in a wound, comprising contacting blood from the wound at the site of the wound with a composition comprising polyphosphate (polyP n ), wherein n is at least 25.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2011
From: DOCAMPO, ROBERTO; MUTCH, NICOLA J.; MORRISSEY, JAMES H.; SMITH, STEPHANIE A.
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 027235/0052 →
CONFIRMATORY LICENSE Recorded Mar 4, 2010
From: UNIVERSITY OF ILLINOIS URBANA-CHAMPAGNE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024026/0636 →
Continuity (3)
Continuation 11362270 · Feb 23, 2006
Provisional Application 60658776 · Mar 4, 2005
Related Publication 20100143492A1 · Jun 10, 2010